Virtu Financial LLC Atai Life Sciences N.V. Transaction History

Virtu Financial LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$1.27 - $2.6 $59,630 - $122,077	46,953 New	46,953 $62,000
Q4 2023 Feb 26, 2024	BUY	$1.04 - $1.55 $30,305 - $45,167	29,140 New	29,140 $41,000
Q2 2023 Jul 27, 2023	BUY	$1.44 - $2.19 $34,032 - $51,758	23,634 New	23,634 $41,000
Q3 2022 Nov 07, 2022	BUY	$3.14 - $4.87 $144,408 - $223,971	45,990 New	45,990 $152,000
Q1 2022 May 17, 2022	SELL	$4.66 - $7.66 $170,416 - $280,126	-36,570 Closed	0 $0
Q4 2021 Feb 17, 2022	BUY	$6.82 - $17.8 $249,407 - $650,946	36,570 New	36,570 $279,000

12.4M

77.8K

50.3K

Ticker ATAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 165,875,008
Market Cap $197M
Description
Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.